Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:10.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the expected study record for NCT04123704, indicating an access restriction. This blocks viewing the study details on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-19T20:59:10.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This reflects a new version of the study record and associated documents, without altering the trial details.
    Difference
    0.1%
    Check dated 2026-08-29T20:08:35.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now shown on the page, replacing v3.6.4. This reflects a new version of the page; no study content or user-facing features are changed.
    Difference
    0.1%
    Check dated 2026-08-08T17:59:19.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.3 to v3.6.4. This represents a minor backend/software update rather than a change to the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-25T09:26:14.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.3, replacing the previous v3.6.2. This indicates a minor site update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-03T21:46:47.000Z thumbnail image

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.